Javascript is required
Search
/
/
Healthcraft Frontiers
GSI
Healthcraft Frontiers (HF)
IDA
ISSN (print): 3005-7981
ISSN (online): 3005-799X
Submit to HF
Review for HF
Propose a Special Issue
Current State
Issue
Volume
2025: Vol. 3
Archive
Home

Healthcraft Frontiers (HF) is dedicated to advancing multidisciplinary research in health sciences. It focuses on publishing innovative and comprehensive findings that push the boundaries of current knowledge in health and well-being. The journal emphasizes an integrative approach, blending traditional practices with groundbreaking research, to drive advancements in health care. It seeks scholarly contributions that challenge established theories and provide practical solutions and insights with global public health and policy implications. The journal typically releases its four issues in March, June, September, and December each year.

  • Professional Service - Every article submitted undergoes an intensive yet swift peer review and editing process, adhering to the highest publication standards.

  • Prompt Publication - Thanks to our expertise in orchestrating the peer-review, editing, and production processes, all accepted articles are published rapidly.

  • Open Access - Every published article is instantly accessible to a global readership, allowing for uninhibited sharing across various platforms at any time.

Editor(s)-in-chief(1)
wei qian
College of Medicine and Biological Information Engineering, Northeastern University, China
wqian@bmie.neu.edu.cn | website
Research interests: Computer-Aided Cancer Diagnosis; Medical Big Data Analysis; Computer-Assisted Analysis of Radiotherapy Plans

Aims & Scope

Aims

Healthcraft Frontiers (HF) seeks to advance the multidisciplinary dialogue in health sciences by showcasing research that challenges and extends current knowledge boundaries. The journal's aim is to publish comprehensive and innovative findings in the health domain, supporting a broadened understanding of health and well-being. Emphasis is placed on integrative approaches that combine traditional practices with cutting-edge research to foster breakthroughs in health care. Scholarly contributions are expected to not only question established theories but also offer tangible solutions and insights that have the potential to influence public health and policy on a global scale.

Furthermore, HF highlights the following features:

  • Every publication benefits from prominent indexing, ensuring widespread recognition.

  • A distinguished editorial team upholds unparalleled quality and broad appeal.

  • Seamless online discoverability of each article maximizes its global reach.

  • An author-centric and transparent publication process enhances submission experience.

Scope

HF's expansive scope encompasses, but is not limited to:

  • Advanced biomedical research that pushes the frontiers of genetic, molecular, and cellular understandings of health and disease.

  • Public health studies that go beyond traditional epidemiology to include global health security, health economics, and the impact of health policies on disease prevention and management.

  • Behavioral and mental health research that explores new therapeutic paradigms, including the integration of technology in treatment and the role of digital health in modern healthcare.

  • Environmental health research that considers the complex interactions between humans and their environments, including studies on climate change, pollution, and urban health.

  • Nutrition and lifestyle studies that examine the influence of diet, exercise, and lifestyle choices on health and chronic disease management.

  • Health systems and policy research focused on the analysis and design of healthcare delivery systems, aiming to improve quality, efficiency, and equity in healthcare.

  • Translational research that includes the development of new diagnostic tools, vaccines, and therapeutics, emphasizing rapid translation of research into practice.

  • Innovations in healthcare technology, including telemedicine, health informatics, and the use of artificial intelligence in healthcare settings.

  • Integrative and complementary medicine studies that evaluate the efficacy and integration of alternative healing practices into conventional medicine.

  • Patient-centered research that emphasizes patient engagement, experience, and outcomes in the design and evaluation of healthcare interventions.

    Healthcraft Frontiers encourages submissions that not only contribute to their respective fields but also cross-pollinate ideas among various health disciplines, ultimately aiming to catalyze interdisciplinary research and innovation for a healthier global society.

Articles
Recent Articles
Most Downloaded
Most Cited

Abstract

Full Text|PDF|XML

Drug-therapy problems (DTPs) are a major concern in cardiovascular disease (CVD) management, particularly among older adults exposed to polypharmacy, drug-drug interactions (DDIs), non-adherence, unnecessary drug therapy, and adverse drug reactions (ADRs). This prospective observational study, conducted in the cardiology unit of Saidu Group of Teaching Hospital (SGTH), Swat, Pakistan, evaluated 350 inpatients admitted from January to March 2022. Data were analyzed using SPSS v26 and GraphPad Prism v5.01, employing chi-square tests, t-tests, and binary logistic regression (p < 0.05). A total of 323 patients (92.29%) experienced at least one DTP, accounting for 1,252 events. DDIs were the most common DTP, followed by unnecessary drug therapy and ADRs. Age was a significant predictor, with the highest odds of DTPs observed in patients aged 61–70 years; a slight, non-significant increase was noted among females and those with polypharmacy (>5 medications). DTP frequency correlated positively with age and the number of prescribed medications, particularly among individuals aged 31–70 years. The findings indicate a high burden of preventable DTPs in CVD management, dominated by DDIs and unnecessary drug therapy. The incorporation of multidisciplinary medication-review teams, strengthened clinical decision support systems (CDSS), and routine prescription audits is recommended to mitigate DTPs and enhance the safety and precision of cardiovascular pharmacotherapy.

Open Access
Research article
Hybrid Deep Learning Architecture for Automated Chest X-ray Disease Detection with Explainable Artificial Intelligence
b. vivekanandam ,
kambala vijaya kumar ,
jagadeeswara rao annam
|
Available online: 05-08-2025

Abstract

Full Text|PDF|XML
Deep learning (DL) has increasingly been adopted to support automated medical diagnosis, particularly in radiological imaging where rapid and reliable interpretation is essential. In this study, a hybrid architecture integrating convolutional neural network (CNN), residual networks (ResNet), and densely connected networks (DenseNet) was developed to improve automated disease recognition in chest X-ray images. This unified framework was designed to capture shallow, residual, and densely connected representations simultaneously, thereby strengthening feature diversity and improving classification robustness relative to conventional single-model or dual-model approaches. The model was trained and evaluated using the ChestX-ray14 dataset, comprising more than 100,000 X-ray images representing 14 thoracic disease classes. Performance was assessed using established metrics, including accuracy, precision, recall, F1-score, and the area under the receiver operating characteristic curve (AUC-ROC). A classification accuracy of 92.5% was achieved, representing an improvement over widely used machine learning (ML) and contemporary DL baselines. To promote transparency and clinical interpretability, Gradient-weighted Class Activation Mapping (Grad-CAM) was incorporated, enhancing clinician confidence in model decisions. The findings demonstrate that DL-based diagnostic support systems can reduce diagnostic uncertainty, alleviate clinical workload, and facilitate timely decision-making in healthcare environments. The proposed hybrid model illustrates the potential of advanced feature-integration strategies to improve automated radiographic interpretation and underscores the importance of explainable artificial intelligence (XAI) in promoting trustworthy deployment of medical artificial intelligence (AI) technologies.

Abstract

Full Text|PDF|XML

Diabetic foot infections (DFIs) are a major cause of morbidity and lower-limb amputations among individuals with diabetes mellitus. Inappropriate empirical antibiotic use contributes to treatment failure and elevated amputation risk. This observational study, conducted across six hospitals in Khyber Pakhtunkhwa (KP), Pakistan, involved 341 patients with clinically diagnosed DFIs. The objectives were to evaluate antibiotic efficacy, treatment outcomes, and risk factors for amputation, and to develop a visual risk stratification model correlating antibiotic response with amputation risk. The cohort exhibited a significant male predominance (64.5%, p = 0.003), with the highest prevalence among patients aged 41–50 years (36.7%). Most participants were insulin-independent (92.7%, p < 0.0001). Infection severity was mild in 28.7%, moderate in 47.8%, and severe in 23.5% of cases. Clinical outcomes included complete recovery (39.3%), improvement (31.7%), progression (19.9%), and amputation (9.1%). High-efficacy antibiotics included Levofloxacin (Levaquin, 100%), Colistin (100%), and Linezolid (Zyvox, 86.6%), whereas Ceftriaxone (Cefzone, 33.3%), Ampicillin/Sulbactam (Penro, 38.3%), and Clindamycin (Cleocin HCl, 26.6%) demonstrated limited therapeutic benefit. The visual stratification model showed that exposure to low-efficacy antibiotics significantly increased amputation risk. Logistic regression identified severe baseline infection (odds ratio (OR) ≈3.2), poor glycemic control (OR ≈ 1.9), and treatment with low-efficacy antibiotics (OR ≈ 2.8) as independent predictors of unfavorable outcomes. This study highlights the need for region-specific antibiotic stewardship, continuous resistance surveillance, and evidence-based treatment protocols. The proposed visual model offers a practical framework for guiding empirical therapy and reducing amputation rates in DFI management.

Abstract

Full Text|PDF|XML
The pervasive integration of plastic materials into contemporary society has yielded substantial societal and economic advantages, yet has concurrently precipitated growing toxicological concerns with significant implications for human health. This study critically examines the multifaceted health impacts associated with chronic exposure to microplastics and plastic-derived chemical additives, including phthalates, bisphenol A (BPA), flame retardants, and heavy metals. Through a comprehensive synthesis of recent toxicological and epidemiological evidence, the mechanisms through which these contaminants disrupt endocrine regulation, impair immune homeostasis, and compromise cellular function are elucidated. Cumulative exposure has been linked to heightened incidences of hormone-related disorders, carcinogenesis, metabolic syndromes, and neurodevelopmental abnormalities. Recent advances in analytical detection techniques have confirmed the systemic distribution and bioaccumulation of microplastic particles across human organs. Environmental vectors—such as air, water, soil, and food contamination—serve as major conduits of microplastic exposure, amplifying indirect toxicological risks through trophic transfer and persistent environmental deposition. Despite the mounting evidence of harm, current regulatory frameworks remain fragmented and insufficiently stringent, reflecting a lag between scientific understanding and policy enforcement. Addressing these deficiencies requires a paradigm shift from reactive risk management toward proactive prevention, encompassing the development of biodegradable materials, reinforcement of global monitoring systems, and the establishment of harmonized exposure thresholds. The synthesis presented herein highlights the urgent necessity of redefining plastic consumption and waste management practices to safeguard both human and ecological health, advocating for integrative strategies that align environmental sustainability with public health protection.
Open Access
Research article
Artificial Intelligence and Machine Learning in Smart Healthcare: Advancing Patient Care and Medical Decision-Making
Anil Kumar Pallikonda ,
Vinay Kumar Bandarapalli ,
vipparla aruna
|
Available online: 03-27-2025

Abstract

Full Text|PDF|XML

The transformative potential of artificial intelligence (AI) and machine learning (ML) in healthcare has been increasingly recognized, particularly in medical image analysis and predictive modeling of patient outcomes. In this study, a novel convolutional neural network (CNN) architecture incorporating customized skip connections was introduced to enhance feature extraction and accelerate convergence during medical image classification. This model demonstrated superior performance compared with conventional architectures such as Residual Network with 50 layers (ResNet-50) and Visual Geometry Group with 16 layers (VGG16), achieving an accuracy of 96.5% along with improved precision, recall, and area under the receiver operating characteristic curve (AUC-ROC). In parallel, patient readmission risks were predicted using an optimized random forest algorithm, which, after hyperparameter tuning, attained a robust AUC-ROC value of 0.91, thereby underscoring its stability and predictive reliability. The integration of these approaches highlights the ability of AI and ML systems to deliver more accurate diagnoses, anticipate potential health risks, and recommend personalized treatment strategies, ultimately enabling faster and more precise clinical decision-making. Despite these advancements, challenges persist regarding data privacy, interpretability of AI-driven decisions, and the ethical use of patient information. Addressing these limitations will be critical for the broader adoption of AI-enabled healthcare systems. The findings of this study reinforce the role of advanced AI and ML frameworks in improving healthcare delivery, optimizing the use of limited resources, and reducing operational costs, thereby supporting more effective patient care.

Abstract

Full Text|PDF|XML

Accurate evaluation of tibial mechanical properties is essential for the diagnosis of bone-related disorders, the monitoring of fracture healing, and the optimization of orthopedic rehabilitation outcomes. Conventional diagnostic approaches, including dual-energy X-ray absorptiometry (DXA) and other imaging-based methods, provide valuable information but are limited by radiation exposure, invasiveness, or insufficient sensitivity to early structural changes. To address these limitations, non-invasive vibration-based techniques have been developed as promising alternatives for quantitative, real-time, and radiation-free assessment of tibial biomechanics. Methods such as resonance frequency analysis (RFA), modal analysis, acoustic emission (AE), and laser doppler vibrometry (LDV) have been applied to estimate parameters including bone stiffness, bone mineral density (BMD), and healing dynamics. By introducing controlled vibrational input and recording the tibial response, structural integrity can be characterized, and early indicators of injury, degeneration, or impaired healing can be detected. Recent advances in high-resolution sensors, signal processing algorithms, and wearable technologies have enhanced the sensitivity and applicability of these techniques, while the integration of machine learning has enabled more robust interpretation of complex biomechanical signals. Despite these advances, significant challenges remain, including inter-patient variability, soft tissue damping effects, and the absence of standardized testing protocols. Furthermore, the clinical translation of vibration-based diagnostics requires validation against established imaging modalities and the development of predictive, individualized models of bone health that integrate artificial intelligence (AI) and multimodal data. Current evidence suggests that vibration analysis has the potential to offer a non-invasive and personalized approach to skeletal monitoring. Future research should focus on addressing methodological limitations, improving standardization, and advancing the integration of vibration assessment into routine orthopedic practice and precision medicine frameworks.

Abstract

Full Text|PDF|XML

Diabetic foot ulcers (DFUs), often exacerbated by secondary bacterial infections, are a major complication of diabetes and a leading cause of morbidity. Understanding the spectrum of bacterial pathogens and their profiles of antibiotic resistance is essential for developing effective treatment strategies. This study aimed to identify bacterial isolates from the DFUs and evaluate their susceptibility to commonly used antibiotics. A total of 186 patients with the DFUs were examined at Hayatabad Medical Complex of Peshawar in Pakistan over a three-month period. Samples were collected from infected ulcer sites and cultured with standard microbiological techniques. Bacterial identification was performed with conventional methods, and antibiotic susceptibility testing was then conducted by using the Kirby-Bauer disk diffusion method. Gram-Negative bacteria were predominant, with Pseudomonas aeruginosa, Proteus mirabilis, Acinetobacter spp., Escherichia coli, Klebsiella spp., Enterobacter spp., and Streptococcus pyogenes being the most commonly isolated organisms. Gram-Positive isolates including Staphylococcus aureus and Staphylococcus epidermidis, P. aeruginosa, and Enterobacter spp. showed high sensitivity to Gentamicin, Meropenem, and Imipenem. In contrast, Acinetobacter spp. and Klebsiella spp. exhibited significant resistance, particularly to carbapenems. Staph. aureus was generally sensitive to first-line antibiotics, such as Vancomycin and Rifampicin whereas Staph. epidermidis demonstrated multidrug resistance including pan-drug resistance in some cases. These findings highlighted the complex and resistant microbial profiles of diabetic foot infections, thus emphasizing the importance of the culture-guided antibiotic therapy. The emergence of carbapenem-resistant strains underlined the requisites for continuous surveillance, judicious antibiotic use, and improved infection control strategies to aid the recovery of patients.

Abstract

Full Text|PDF|XML

Diabetes mellitus (DM) is a major non-communicable metabolic disorder characterized by persistent hyperglycemia arising from impaired insulin secretion, insulin resistance, or a combination of both. As the global burden of DM continues to rise, understanding its prevalence and associated risk factors in specific populations is critical for the development of effective prevention and management strategies. A cross-sectional study was conducted among 150 residents (75 males and 75 females) attending a tertiary healthcare facility in Mardan, Pakistan. Sociodemographic characteristics, family history, body mass index (BMI), lifestyle behaviors, dietary patterns, psychological stress, and other potential risk factors were assessed using a structured questionnaire, while venous blood samples were collected to confirm the diagnosis of DM. Overall, the prevalence of DM was found to be 34.67% (n=52), with 29.33% (n=44) previously diagnosed and 5.33% (n=8) newly identified during the investigation. A significant sex-related disparity was observed, with prevalence rates of 26.67% (n=20) in males and 42.67% (n=32) in females. Rural residents exhibited a higher prevalence (42.86%, n=33) compared to urban residents (26.03%, n=19). Several risk factors demonstrated a notable association with DM, including advanced age (>60 years: 8.67%, n=13), obesity (12.67%, n=19), low physical activity (26.67%, n=40), smoking (11.33%, n=17), unhealthy dietary patterns (27.33%, n=41), high psychological stress (17.33%, n=26), hypertension (14%, n=21), and a positive family history (27.33%, n=41). The findings indicate an upward trend in the prevalence of DM in the Mardan region. Immediate implementation of targeted interventions, including public health education, lifestyle modification, dietary counseling, and risk factor management, is essential to mitigate the increasing burden of DM in this population.

Abstract

Full Text|PDF|XML

Celiac disease (CD) is an autoimmune disorder triggered by gluten in genetically susceptible individuals, and viral infections have been proposed as potential cofactors in its pathogenesis. This study investigated the replication of SEN virus genotypes H and D in CD patients and their association with systemic cytokine levels. A total of 276 participants were enrolled, including 192 CD patients—115 on a gluten-containing diet (GCD) and 77 on a gluten-free diet (GFD)—alongside 84 healthy controls. SEN virus detection was performed using nested PCR, and serum cytokine levels (IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, IFN-γ) were quantified via ELISA. SENV-H was detected in 71.4% of CD patients on a GCD, 66.7% of those on a GFD, and only 19.0% of healthy controls. In contrast, SENV-D was found exclusively in healthy individuals (23.8%) and not in CD patients. CD patients on a GCD exhibited markedly elevated cytokine levels, particularly IL-6 (76.2 ± 12.3 pg/mL), IL-8 (112.0 ± 40.2 pg/mL), and IFN-γ (50.2 ± 15.2 pg/mL), compared to GFD patients and healthy controls. Multivariate logistic regression identified IL-1, IL-2, IL-4, IL-6, IL-8, and IL-10 as significantly associated with active disease (ORs < 1, p < 0.05). Strong to very strong positive correlations were observed between SENV-H positivity and cytokine levels, with IL-6, IL-8, and IL-1 each showing correlation coefficients around 0.99. These results suggest that SENV-H may play a role in promoting or amplifying mucosal immune responses in active CD, whereas SENV-D appears unrelated. The findings highlight a potential interaction between viral replication and immune activation in celiac disease, meriting further mechanistic investigation.

Abstract

Full Text|PDF|XML
Brain tumors constitute a heterogeneous and life-threatening group of neurological disorders in which timely and accurate diagnosis is critical to improving patient outcomes. Conventional diagnostic practices, which rely heavily on manual interpretation of medical imaging, remain constrained by inter-observer variability, subjective judgment, and limited reproducibility, particularly when assigning tumor grades according to the World Health Organization (WHO) classification system. In recent years, machine learning (ML) and deep learning (DL) have emerged as transformative computational paradigms capable of automating complex pattern recognition in neuroimaging and enhancing diagnostic precision, efficiency, and consistency. A comprehensive review of ML/DL-based approaches for brain tumor analysis is presented in this study, encompassing key methodologies developed for tumor detection, segmentation, and classification across WHO grades. Despite notable research advances, clinical adoption remains impeded by several critical challenges, including insufficient dataset size and heterogeneity, a lack of model interpretability, limited generalizability across imaging acquisition protocols, and barriers associated with clinical integration and regulatory approval. Addressing these obstacles will require the development of large-scale, standardized, and multi-institutional datasets; the advancement of explainable artificial intelligence (XAI) frameworks to enhance clinical trust; and the incorporation of multi-modal patient data to improve diagnostic robustness. Furthermore, the convergence of ML/DL with emerging technologies such as blockchain and the Internet of Things (IoT) holds promise for enabling privacy-preserving, interoperable, and real-time diagnostic platforms. With continued advancements in algorithmic robustness, interpretability, and cross-institutional validation, ML/DL-based frameworks hold the potential to revolutionize brain tumor diagnosis and classification, ultimately improving diagnostic precision, prognostic assessment, and personalized treatment planning.

Abstract

Full Text|PDF|XML

Diabetic foot infection (DFI) represents a severe and potentially limb-threatening complication of long-standing and poorly controlled diabetes mellitus, a condition currently affecting over 422 million individuals globally and associated with more than 2 million annual deaths. This retrospective observational study was conducted at Hayatabad Medical Complex (HMC), Peshawar, with the objective of characterizing the clinical features, comorbidities, antibiotic regimens, and management outcomes of patients diagnosed with DFI. Clinical records of 341 patients admitted over a three-month period were reviewed. A male predominance was observed, with the highest prevalence noted among individuals aged 40–60 years. The majority of cases involved insulin-dependent diabetes mellitus, and an extended disease duration was identified as a major predisposing factor for DFI development. The mean hospitalization period was 25 days. Notably, complications such as peripheral neuropathy, diabetic nephropathy, and peripheral vasculopathy were more frequently documented in patients aged 65 years and older. Empirical treatment commonly involved poly-antibiotic regimens, which were administered in 64.81% of cases, underscoring the polymicrobial nature and severity of infections encountered. An amputation rate of 44.07% was recorded, which exceeds figures reported in comparable regional studies and is likely attributable to delayed clinical presentation and advanced stages of infection at the time of admission. The findings underscore the urgent need for enhanced early screening protocols, timely initiation of pathogen-targeted antimicrobial therapy, and multidisciplinary surgical intervention to reduce the risk of lower extremity amputation and the associated socio-economic burden.

Open Access
Research article
Machine Learning for Diabetes Prediction: Performance Analysis Using Logistic Regression, Naïve Bayes, and Decision Tree Models
rupinder kaur ,
raman kumar ,
Swapandeep Kaur ,
gurneet singh ,
arshnoor kaur ,
sukhpal singh
|
Available online: 12-30-2024

Abstract

Full Text|PDF|XML

Diabetes is a chronic metabolic disorder that affects millions of people worldwide, making early detection crucial for effective management. This study assesses the effectiveness of three machine learning (ML) models, Logistic Regression (LR), Naïve Bayes (NB), and Decision Tree (DT), in predicting diabetes based on data from 392 individuals, including their demographic and clinical characteristics. The dataset underwent preprocessing to maintain data integrity, was standardized for model compatibility, and analyzed through feature correlation heatmaps, feature importance assessments, and statistical significance tests. The findings revealed that LR surpassed the other models, with the highest accuracy (78%), precision (73%), and F1-score (65%) for diabetic cases. NB showed moderate performance with 75% accuracy, while DT demonstrated the lowest accuracy (71%) due to overfitting. Receiver Operating Characteristic (ROC) analysis revealed strong discriminative power across all models, although perfect Area Under the Curve (AUC) scores indicate potential overfitting needing further validation. The study emphasizes the significance of key features like Glucose, Body Mass Index (BMI), and Age, which showed notable differences between diabetic and non-diabetic individuals. By enabling early detection and proactive management, these models can contribute to reducing diabetes-related complications, enhancing patient outcomes, and lessening the burden on healthcare systems. Future research should investigate ensemble learning, deep learning, and real-time data integration from Internet of Things (IoT) devices to improve predictive accuracy and scalability.

load more...
- no more data -
Most cited articles, updated regularly using citation data from CrossRef.
- no more data -